130 related articles for article (PubMed ID: 33608452)
1. Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.
Chen JH; Duan H; Yu XB; Zhao HW; Chen X; Li P; Li ZQ; Li BX; Pan LY; Yan X; Chen C
Int J Gynecol Cancer; 2021 Apr; 31(4):512-517. PubMed ID: 33608452
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of 16 cases of villoglandular adenocarcinoma of uterine cervix].
Zhu X; Wu M; Tan X; Yu Q
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(7):519-22. PubMed ID: 25916928
[TBL] [Abstract][Full Text] [Related]
3. Well-Differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis.
Khunamornpong S; Maleemonkol S; Siriaunkgul S; Pantusart A
J Med Assoc Thai; 2001 Jun; 84(6):882-8. PubMed ID: 11556470
[TBL] [Abstract][Full Text] [Related]
4. Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?
Ju UC; Kang WD; Kim SM
J Gynecol Oncol; 2018 Jul; 29(4):e54. PubMed ID: 29770624
[TBL] [Abstract][Full Text] [Related]
5. [Villoglandular adenocarcinoma of the cervix uteri. A case report and analysis of the literature].
Wiesenfeld U; Baraggino E; Melato M
Minerva Ginecol; 1997 May; 49(5):221-4. PubMed ID: 9304084
[TBL] [Abstract][Full Text] [Related]
6. Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome.
Guo P; Liu P; Yang J; Ren T; Xiang Y
Cancer Manag Res; 2018; 10():3955-3961. PubMed ID: 30310316
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.
Kim HJ; Sung JH; Lee E; Ahn S; Song SY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Int J Gynecol Cancer; 2014 Sep; 24(7):1299-305. PubMed ID: 24987921
[TBL] [Abstract][Full Text] [Related]
8. Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification.
Stolnicu S; Brito MJ; Karpathiou G; Hoang L; Felix A; Mateoiu C; Fanni D; Reques A; Garcia A; Hardisson D; Talu CK; Furtado A; Abu-Rustum N; Soslow RA; Park KJ
Int J Gynecol Pathol; 2023 May; 42(3):270-277. PubMed ID: 36508680
[TBL] [Abstract][Full Text] [Related]
9. Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.
Dietl AK; Beckmann MW; Aumann K
Arch Gynecol Obstet; 2021 Aug; 304(2):317-327. PubMed ID: 34036437
[TBL] [Abstract][Full Text] [Related]
10. Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing.
Bouman A; Oosterhuis GJ; Naudin ten Cate L; van Doorn GA
Eur J Obstet Gynecol Reprod Biol; 1999 Dec; 87(2):183-9. PubMed ID: 10597972
[TBL] [Abstract][Full Text] [Related]
11. Villoglandular adenocarcinoma of the cervix: a case report.
Hurteau JA; Rodriguez GC; Kay HH; Bentley RC; Clarke-Pearson D
Obstet Gynecol; 1995 May; 85(5 Pt 2):906-8. PubMed ID: 7724158
[TBL] [Abstract][Full Text] [Related]
12. Tumor Handling of Early-stage Cervical Cancer: A Literature Analysis of Villoglandular Adenocarcinoma of the Cervix.
Dietl A; Aumann K; Beckmann MW
Anticancer Res; 2020 Jun; 40(6):3049-3053. PubMed ID: 32487598
[TBL] [Abstract][Full Text] [Related]
13. Papillary villoglandular carcinoma of the cervix.
Hopson L; Jones MA; Boyce CR; Tarraza HM
Gynecol Oncol; 1990 Nov; 39(2):221-4. PubMed ID: 2227600
[TBL] [Abstract][Full Text] [Related]
14. Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis.
Macdonald RD; Kirwan J; Hayat K; Herrington CS; Shawki H
Gynecol Oncol; 2006 Jan; 100(1):192-4. PubMed ID: 16266744
[TBL] [Abstract][Full Text] [Related]
15. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
[TBL] [Abstract][Full Text] [Related]
16. Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literature.
Stanley-Christian H; Heim BK; Hines JF; Hall KL; Willett GD; Barnes WA
Gynecol Oncol; 1997 Aug; 66(2):327-30. PubMed ID: 9264585
[TBL] [Abstract][Full Text] [Related]
17. A Retrospective Study and Literature Review of Cervical Villoglandular Adenocarcinoma: A Candidate Paradigm of Silva System Pattern A.
Zhang Y; Wang Y; Liu Y; Yang J; Liu C
Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):467-472. PubMed ID: 33337634
[TBL] [Abstract][Full Text] [Related]
18. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract][Full Text] [Related]
19. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?
Smith HO; Qualls CR; Romero AA; Webb JC; Dorin MH; Padilla LA; Key CR
Gynecol Oncol; 2002 May; 85(2):229-41. PubMed ID: 11972381
[TBL] [Abstract][Full Text] [Related]
20. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
